Sociological Impact of COVID-19 on People with Non-Communicable Diseases (NCD) and Long COVID-19 in Young Children


  • ASITA ELENGOE Department of Biotechnology, Faculty of Science, Lincoln University College, Malaysia
  • KAMOKA HANA MOFTAH IBRAHEM Department of Biotechnology, Faculty of Science, Lincoln University College, 47301 Petaling Jaya, Selangor, Malaysia
  • ABDULMUTALIB ALABEED ALLAQ Faculty of Applied Sciences, Universiti Teknologi MARA, 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
  • ALABED ALI AHMED ALABED Lincoln University College, 47301 Petaling Jaya, Selangor, Malaysia



COVID-19, Non-communicable diseases, SARS-CoV-2, Young children


The Coronavirus Disease 2019 (COVID-19) pandemic has posed enormous health
risks worldwide. In the 21st century, a novel virus which is called SARS-CoV-2; was
the main cause for the COVID-19 pandemic outbreak. This virus is transmitted from
person to person through direct and indirect transmission. Some infected people develop serious symptoms, but others do not show any symptoms. Infected people with
no visible symptoms could also transmit the viruses. Literature studies about the
COVID-19 pandemic (starts from Dec 2020 until June 2021) were conducted
through PubMed, Embase, Medline and Google Scholar. In this study, we explored
the COVID-19's impact on non-communicable diseases and young children. Scientists are currently testing several drugs to eradicate the COVID-19 outbreak. Pfizer,
AstraZeneca, Sinovac and Moderna, vaccine doses administrated successfully
throughout the world. Government agencies also implemented certain rules and regulations to protect their citizens from coronavirus. Moreover, World Health Organization (WHO) also helps by providing many valuable information and precautions
to countries. Hence, this study might provide some information on how to deal with
the virus to curb the rapid spread of the SARS-CoV-2.
Keywords: COVID-19, Non-communicable diseases, SARS-CoV-2, Young children

Author Biography

ALABED ALI AHMED ALABED, Lincoln University College, 47301 Petaling Jaya, Selangor, Malaysia

Department of Community Medicine, Faculty of Medicine,


Singhal T (2020) A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics 87(4): 281-286.

Elengoe A (2020) COVID-19 outbreak in Malaysia. Osong Public Health and Research Perspectives 11(3): 93.

COVID-19 Coronavirus pandemic. Worldometer. Accessed: 22 June, 2021.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, ... & Yan Y (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research 7(1): 1-10.

World Health Organization. Coronavirus disease (COVID-19): Vaccines. Accessed: 28 October, 2020.

Forni G, Mantovani A (2021) COVID-19 vaccines: where we stand and challenges ahead. Cell Death & Differentiation 28(2): 626-639.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei C, Hui DSC (2020) Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 382(18): 1708-1720.

Hotchin NA, Read R, Smith D, Crawford, DH (1989). Active Epstein-Barr virus infection in post-viral fatigue syndrome. Journal of Infection 18(2): 143-150.

Gaiha SM, Cheng J, Halpern-Felsher B (2020) Association between youth smoking, electronic cigarette use, and COVID-19. Journal of Adolescent Health 67(4): 519-523.

Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R (2020) World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76, 71–76.

Ost DE (2020). Bronchoscopy in the Age of COVID-19. Journal of Bronchology & Interventional Pulmonology 27(3): 160-162.

Cheung JCH, Ho LT, Cheng JV, Cham EYK, Lam KN (2020)N Staff safety during emergency airway management for COVID-19 in Hong Kong. The Lancet Respiratory Medicine 8(4): e19.

Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Della Casa G, ... & Maher TM (2020) Pulmonary fibrosis secondary to COVID-19: a call to arms?. The Lancet Respiratory Medicine 8(8): 750-752.

Han Y, Saran R (2020) Global Dialysis Perspective: United States. Kidney360.

Hosen MS, Nafiujjaman M, Nishat TR (2021) Alleviating the Financial Burden for Dialysis Patients in Low-and Middle-Income Countries during the COVID-19 Pandemic. International Journal of Health Life Science, 7(1), e106682.

Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, & Lindholm, B (2008) Aspects of immune dysfunction in end-stage renal disease. Clinical Journal of the American Society of Nephrology 3(5): 1526-1533.

Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine 8(4): e21.

O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports 51(RR-10): 1-29.

Chang AY, Cullen MR, Harrington RA, Barry M (2021) The impact of novel coronavirus COVIDâ€19 on noncommunicable disease patients and health systems: a review. Journal of Internal Medicine, 289(4): 450-462.

Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, Gu H, Hirth RA, Hutton D, Jin, Y (2020) US renal data system 2019 annual data report: epidemiology of kidney disease in the United States.

Prevention C. for D. C. and. (n.d.). People who are at increased risk for severe illness. Accessed: 29 April, 2020.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology 21(3): 335-337.

Xia Y, Jin R, Zhao J, Li W, Shen H (2020) Risk of COVID-19 for cancer patients. Lancet Oncology: 21(4).

24. Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. The Journal of the American Society of Hematology, 135(23): 2033-2040.

Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowensâ€Alvarado R L, Cannady RS, Prattâ€Chapman ML, Edge SB, Jacobs LA (2016) American cancer society/American society of clinical oncology breast cancer survivorship care guideline. CA: A Cancer Journal for Clinicians 66(1): 43-73.

Pan L, Mu M, Yang P, Sun, Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C (2020) Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. The American Journal of Gastroenterology: 115.

Gu J, Han B, Wang J (2020) COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 158(6): 1518-1519.

28. Kumar D, Tellier R, Draker R, Levy G, Humar A (2003) Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. American Journal of Transplantation 3(8): 977-981.

Chopra V, Toner E, Waldhorn R, Washer L (2020) How should US hospitals prepare for coronavirus disease 2019 (COVID-19)? American College of Physicians 172(9): 621-622.

Mardani, M. (2020a). Post COVID syndrome. Arch. Clin. Infect. Dis, 15, e108819.

Carfì A, Bernabei R, Landi F (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324(6): 603-605.

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet 395(10237): 1607-1608.

Greenhalgh T, Knight M, Buxton M, Husain L (2020) Management of post-acute COVID-19 in primary care. BMJ: 370.

Ece İ, Koçoğlu M, Kavurt AV, Bağrul D, Gül AEK, Koca S, Çetin İİ, Parlakay ANÖ, Aksoy S (2021) Assessment of cardiac arrhythmic risk in children with COVID-19 infection. Pediatric Cardiology 42(2): 264-268.

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY (2020) Extrapulmonary manifestations of COVID-19. Nature Medicine 26(7): 1017-1032.

Ludvigsson JF (2020) Systematic review of COVIDâ€19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica, 109(6): 1088-1095.

Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, Johnson M, Griffiths B, du Pré P, Mohammad Z (2020) Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. The Lancet Child & Adolescent Health 4(9): 669-677.



2022-02-17 — Updated on 2022-02-17